E N D
1. Intas Biopharmaceuticals Limited Global Biotech Company Located in India
3. Corporate Milestones Established 2000
R&D Center started 2001
Mfg facility operational 2003
Launched rHu G-CSF 2004
Launched rHu EPO 2005
Launched rHu IFN 2007
EU-GMP certification 2007
Facility Expansion 2007
Launched Peg-GCSF 2007
5. Current Portfolio of Products Biotechnology
Filgrastim - Neukine
Erythropoietin - Erykine
Interferon alfa-2b - Intalfa
Peg-Filgrastim - Neupeg
Oncology
Currently 22 products in the domestic oncology market
6. Quality Management System
Quality Theme
“Quality assurance of products and services is the obligation of all employees of the company.”